Is Telix Pharmaceuticals Limited (TLX) a Buy, Sell, or Hold?
Telix Pharmaceuticals Limited
NASDAQ:TLX
$11.29 USD
$0.27 (2.45%)
- Volume
- 56.58K
- Average Volume
- 185.39K
- Market Capitalization
- $3.82B
- P/E Ratio
- -486.29
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $16.94
- Year Low
- $6.28
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.43
TLX vs. The Competition
| Properties | TLX | ACAD | ADMA | BLTE |
|---|---|---|---|---|
| Market Cap | $3.82B | $4.44B | $2.01B | $5.99B |
| Shares Outstanding | $338.78M | $171.24M | $231.77M | $40.09M |
| P/E Ratio | -486.29 | 11.62 | 12.58 | -58.62 |
| EPS | -0.03 | 2.2 | 0.7 | -2.26 |
| Day Low | 11.08 | 25.1804 | 8.61 | 144.32 |
| Day high | 11.29 | 26.08 | 8.845 | 150.365 |
| Year Low | 6.28 | 19.69 | 7.21 | 59.12 |
| Year High | 16.94 | 28.35 | 20.458 | 200 |
| Average Price 50 | 10.3954 | 22.7308 | 8.5486 | 146.7823 |
| Average Price 200 | 9.28338 | 23.36815 | 13.70713 | 145.28317 |
| Volume | 56582 | 1.27M | 2.06M | 99678 |
| Average Volume | - | - | - | - |